A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home Archive for category "Therapies" (Page 3)
formats

Interesting 2012 Presentation by Setpoint Medical on Neuromodulation for Treating Chronic Inflammatory Diseases

I found online the PowerPoint presentation for: R Zitnik, Y Levine, M Faltys, T Arnold, “Harnessing the Inflammatory Reflex: Using Neuromodulation as a Novel Approach to Treat Chronic Inflammatory Diseases”, North American Neuromodulation Society Meeting 2012. The presentation shows some preliminary animal results, presents an artist’s conception of the implantable system, and concludes as follows:

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Interesting 2012 Presentation by Setpoint Medical on Neuromodulation for Treating Chronic Inflammatory Diseases  comments 
formats

Cyberonics Reports 12.4% Increase in VNS Sales for Fiscal Q1 2014

Net product sales increased 12.4% to $67.4 million in the first fiscal quarter ended July 26 for Cyberonics, Inc. of Houston, TX. Including license revenue, sales were up 14.2% overall, with Europe in particular contributing a strong performance. Diluted earnings per share were adjusted by $0.17 cents due to a litigation settlement. According to the

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Cyberonics Reports 12.4% Increase in VNS Sales for Fiscal Q1 2014  comments 
formats

Autonomic Technologies’ Sphenopalatine Ganglion Stimulator Treats Cluster Headaches

Autonomic Technologies, Inc. (ATI) is a medical device company located in the San Francisco Bay Area focused on the development of neurostimulators for the treatment of severe headache. The company’s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache and is currently being investigated in a multi-center, randomized

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Autonomic Technologies’ Sphenopalatine Ganglion Stimulator Treats Cluster Headaches  comments 
formats

Cleveland FES Center’s Networked Neural Prosthesis

The Cleveland FES Center was established in 1991 as a consortium between the Cleveland VA Medical Center (CVAMC), the private educational institution of Case Western Reserve University (CWRU), and the public hospital system of MetroHealth Medical Center (MHMC). As part of this consortium, Dr. Hunter Peckham – biomedical engineering professor at Case Western Reserve University –

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Cleveland FES Center’s Networked Neural Prosthesis  comments 
formats

SetPoint Medical Secures $27M to Develop VNS Device to Treat Inflammatory Diseases

SetPoint Medical, headquartered in Valencia, California, is developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), psoriasis, diabetes, heart disease, and multiple sclerosis. SetPoint’s proprietary neuromodulation platform consists of an implantable “microregulator”, wireless charger and iPad prescription pad application. SetPoint announced today that it has secured

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on SetPoint Medical Secures $27M to Develop VNS Device to Treat Inflammatory Diseases  comments 
formats

Medtronic Implants first Activa® PC+S DBS IPG Capable of Sensing and Recording Brain Activity While Delivering Therapy

Medtronic today announced the first implant of the novel Activa® PC+S deep brain stimulation (DBS) system that, for the first time, enables the sensing and recording of select brain activity while simultaneously providing targeted DBS therapy. According to the press release: This initiates research on how the brain responds to the therapy and could yield insights that

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Medtronic Implants first Activa® PC+S DBS IPG Capable of Sensing and Recording Brain Activity While Delivering Therapy  comments 
formats

Medtronic SureScan Neurostimulators Cleared by FDA for Full-Body MRI

Following Medtronic’s announcement in February of this year that it had introduced in Europe the first and only implantable neurostimulation systems indicated for use in the treatment of chronic back and/or leg pain that are designed for full-body Magnetic Resonance Imaging (MRI) scans under specific conditions, the Company announced today that FDA has approved the

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Medtronic SureScan Neurostimulators Cleared by FDA for Full-Body MRI  comments 
formats

Sydney-based Saluda Medical Developing Closed-Loop SCS System for Pain

Start-up company Saluda Medical has been awarded $5M by Australia’s New South Wales Government to support the development of a closed-loop spinal cord stimulation system for the treatment of pain. The difference between other SCS systems and Saluda Medical’s is that the latter – the Implanted Neural Sensing & Stimulation product (INS2) – is that it

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Sydney-based Saluda Medical Developing Closed-Loop SCS System for Pain  comments 
formats

Boston Scientific Launches OPTIMISE Trial of Precision™ Neurostimulator for Treatment of Chronic Migraine

Boston Scientific announced that it has launched a clinical trial to determine whether occipital nerve stimulation (ONS) using the Precision™ System can safely and effectively treat chronic migraine when used in conjunction with anti-migraine medications.   According to the press release:

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific Launches OPTIMISE Trial of Precision™ Neurostimulator for Treatment of Chronic Migraine  comments 
formats

Algostim – Greatbatch’s Own Spinal Cord Stimulation System

  Greatbatch Medical, which moved its headquarters to the Dallas, TX area last year, announced that it has set a target of at least 5%/yr organic growth.  To accomplish this growth, the Company recently announced consolidating operations of its various divisions in order to create efficiency. In addition however, Greatbatch is diversifying from being strictly a

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Algostim – Greatbatch’s Own Spinal Cord Stimulation System  comments 
formats

Enopace Receives Additional $5M Investment for Development of Stimulator for Treatment of Heart Failure

Sorin recently announced a $5 million investment in Israeli startup Enopace Biomedical, which is developing an endovascular neurostimulation system for heart failure.  Back in October 2011 Sorin invested $7 million to finance the initial clinical studies of Enopace’s technology as well as ongoing product development. Very scant details are available besides that it is developing

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Enopace Receives Additional $5M Investment for Development of Stimulator for Treatment of Heart Failure  comments 
formats

Neuromodulation Startup NeuroTronik Raises $13.1M for Development of System for Treating Acute Heart Failure Syndrome

NeuroTronik, a recent spin-off from Synecor, a Chapel Hill business accelerator, announced that it has raised $13.1M for the development of a neuromodulation system intended for the treatment of acute heart failure syndrome. Douglas Reed, a partner in the VC group backing NeuroTronik said that the device aims to shorten hospital stays and reduce the need of

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Neuromodulation Startup NeuroTronik Raises $13.1M for Development of System for Treating Acute Heart Failure Syndrome  comments 
formats

EnteroMedics Submits PMA of the Maestro VBLOC System for Treatment of Obesity

EnteroMedics  reported that it has submitted its pre-market approval application for FDA review of its Maestro Rechargeable System’s VBLOC vagal blocking therapy as a treatment for obesity This is an important step for an implantable device company that faced very tough times in 2009 after its US clinical trial failed to meet a critical effectiveness

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on EnteroMedics Submits PMA of the Maestro VBLOC System for Treatment of Obesity  comments 
formats

NeuroPace Raises $18M of Planned $50M

NeuroPace is a privately-held company in Mountain View, CA. Their RNS® implantable stimulator, along with depth leads and cortical strip leads are designed for the treatment of medically refractory partial epilepsy. Unlike Cyberonics’ VNS IPGs, the RNS neurostimulator is designed to detect abnormal electrical activity in the brain and respond by delivering electrical stimulation to

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on NeuroPace Raises $18M of Planned $50M  comments 
formats

TYRX receives FDA Approval for Fully Resorbable AIGISRx R Antibacterial IPG Envelope

AIGISRx® is an Antibacterial Envelope that is made from knitted polypropylene mesh substrate, coated with a polyarylate bioresorbable polymer containing two antimicrobial antibiotics, minocycline and rifampin. AIGISRx is a dual component (resorbable and non-resorbable), sterile prosthesis designed to reduce infection and to stabilize the implantable pacemaker or defibrillator when implanted in the body.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on TYRX receives FDA Approval for Fully Resorbable AIGISRx R Antibacterial IPG Envelope  comments